Projects
The pharmaceutical projects listed in this section are those that are announced from time to time around the world
Colorcon, Inc. Expands Operations with a New Film Coating Manufacturing Facility in Malaysia
Colorcon, Inc is delighted to announce its recent investment in a stateoftheart manufacturing plant in Johor State, Malaysia
Aurigene Pharmaceutical Services announces plans for biologics CDMO capacity expansion through new biomanufacturing facility
Aurigene Pharmaceutical Services invests $40 million USD in an RD and pilot scale facility, while also securing exclusive access to largescale GMP commercial manufacturing capacity, including fillfinish capabilities
Meissner to Build New US$250 million Manufacturing Facility in USA
Meissner Corporation has recently announced its investment of US$250 million in the construction of a new manufacturing facility in AthensClarke County, Georgia, USA
Catalent Initiates Construction of US$20 million Clinical Supply Facility in Germany
Catalent has initiated the construction of a new clinical supply facility in Schorndorf, Germany, with an investment of US$20 million
Lilly Invests US$1.5 billion for Manufacturing Facilities Expansion in USA
Lilly, has recently announced an investment of US$15 billion in the expansion of its manufacturing facilities in the United States and Ireland
Takeda Invests US$71 million in New Plasma-Derived Therapies Facility in Japan
Takeda is set to invest US$71 million in the construction of a new manufacturing facility for plasmaderived therapies PDTs in Osaka, Japan
PCI Pharma Invests US$50 million for Biologics Facility Expansion in USA
PCI Pharma Services is investing US$50 million to expand its biologics facility in Rockford, Illinois, USA
Boehringer Invests US$285 million in German Chemical Innovation Plant
Boehringer Ingelheim is investing US$285 million to build a new Chemical Innovation Plant at its headquarters in Ingelheim, Germany
Pharmaron Invests US$189 million for Gene Therapy CDMO Expansion in UK
Pharmaron Beijing Co, Limited has allocated a significant investment of US$189 million towards the expansion of its Liverpoolbased Gene Therapy CDMO Contract Development and Manufacturing Organization in the United Kingdom
Amgen to Start Construction of a New Bio Manufacturing Facility in the USA
Amgen has unveiled its plans to build a new biomanufacturing plant in Holly Springs, North Carolina, in the United States The facility will be essential in meeting the rising demand for pharmaceuticals that can save lives and treat a variety of major ailments, including cancer and heart disease
